A Safety, Tolerability, PD and PK Study in Healthy Adults

NCT02211625 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Open-label TRV734 125 mg
DRUG: TRV734 blinded
DRUG: Oxycodone IR 10 mg
DRUG: Placebo

Sponsor

Trevena Inc.